Dan Kisner

Dan Kisner

Direttore/Membro del Consiglio presso ONCTERNAL THERAPEUTICS, INC.
79 anni
Health Technology
Health Services
Consumer Services

Profilo

Daniel L.
Kisner
is currently Chairman at Idun Pharmaceuticals, Inc., Director at Lpath Therapeutics, Inc., and Independent Director at Oncternal Therapeutics, Inc. since 2019.
Former roles include Chairman at Caliper Life Sciences, Inc. from 2002 to 2008; Chairman at Sequoia Pharmaceuticals, Inc.; Chairman at Avera Pharmaceuticals, Inc.; Chairman at Caliper Technologies Corp.
from 2003 to 2008; Chairman at Arbutus Biopharma Corp.
from 2010 to 2015; Director at Pfizer Inc.; Director at Sequenom, Inc.; Director at Kémia, Inc.; Director at Tolerx, Inc. from 2001 to 2011; Director at EMulate Therapeutics, Inc.; Director at KAI Pharmaceuticals, Inc.; Independent Director at Conatus Pharmaceuticals, Inc.; Director at Adaptive Therapeutics, Inc.; Independent Director at Lpath, Inc. from 2012 to 2016; Director at MPEX Pharmaceuticals, Inc.; Director at Symphony Allegro, Inc.; Independent Director at Dynavax Technologies Corp.
from 2010 to 2026; Independent Director at Zynerba Pharmaceuticals, Inc.; Independent Director at Histogen, Inc. from 2014 to 2023; Director at Oncternal Oncology, Inc.; Vice President-Pharmaceutical Development at Abbott Laboratories from 1988 to 1991; President & Chief Operating Officer at Ionis Pharmaceuticals, Inc. from 1991 to 1999; Partner at Aberdare Management Co. LLC.
from 2003 to 2011; Vice President-Clinical Research & Development at Smithkline Beckman Corp from 1985 to 1988.
Education includes undergraduate studies at Rutgers State University of New Jersey and a doctorate from Georgetown University conferred in 1972.

Posizioni attive di Dan Kisner

SocietàPosizioneInizio
ONCTERNAL THERAPEUTICS, INC. Direttore/Membro del Consiglio 07/06/2019
Direttore/Membro del Consiglio -
Presidente -

Precedenti posizioni note di Dan Kisner

SocietàPosizioneFine
DYNAVAX TECHNOLOGIES CORPORATION Direttore/Membro del Consiglio 10/02/2026
Direttore/Membro del Consiglio 01/12/2016
ARBUTUS BIOPHARMA CORPORATION Presidente 01/03/2015
Presidente 08/07/2013
Direttore/Membro del Consiglio 19/12/2011
Vedi nel dettaglio l'esperienza di Dan Kisner

Formazione di Dan Kisner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

80

Relazioni di 1° grado

29

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private29

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Dan Kisner
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA